4-Methylamphetamine


4-Methylamphetamine (also known as 4-MA) is a stimulant of the amphetamine class. It is a substituted amphetamine that is structurally related to amphetamine and methamphetamine.
Chemical Structure[edit]
4-Methylamphetamine is chemically known as 1-(4-methylphenyl)propan-2-amine. It is characterized by the presence of a methyl group attached to the para position of the phenyl ring of the amphetamine backbone. This modification distinguishes it from other amphetamines and contributes to its unique pharmacological properties.
Pharmacology[edit]
4-Methylamphetamine acts primarily as a monoamine releasing agent, promoting the release of neurotransmitters such as dopamine, norepinephrine, and serotonin from presynaptic neurons. This action results in increased concentrations of these neurotransmitters in the synaptic cleft, leading to enhanced stimulation of postsynaptic receptors.
Effects[edit]
The effects of 4-Methylamphetamine are similar to those of other amphetamines, including increased alertness, energy, and euphoria. However, due to its potent action on serotonin release, it may also produce effects similar to those of MDMA, such as increased empathy and sociability.
Toxicity and Safety[edit]
4-Methylamphetamine has been associated with significant neurotoxicity, particularly due to its serotonergic activity. It has been implicated in several cases of serotonin syndrome, a potentially life-threatening condition characterized by excessive serotonergic activity in the central nervous system.
Legal Status[edit]
Due to its potential for abuse and adverse health effects, 4-Methylamphetamine is classified as a controlled substance in many jurisdictions. Its legal status varies by country, but it is generally subject to strict regulation.
Related Compounds[edit]
Related Pages[edit]
Gallery[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian